Search Medical Condition
Please enter condition
Please choose location

Bandung, Indonesia Clinical Trials

A listing of Bandung, Indonesia clinical trials actively recruiting patients volunteers.

RESULTS

Found (5) clinical trials

Validation of the Lupus Low Disease Activity State (LLDAS) in the Asia Pacific Region

In this study, patients with SLE will be followed for ~ 5 years. Regular recordings of the data needed to score LLDAS (disease activity and treatment domains, see Franklyn L et al, Ann Rheum Dis 2016) will be collected, as well as annual recording of lupus-related damage using the SLICC_ACR ...

Phase N/A

0.0 miles

Learn More »

A Study to Evaluate the Efficacy Safety and Immunogenicity of Leucostim Versus Neupogen in Breast Cancer Patients

TAC regimen (docetaxel, doxorubicin and cyclophosphamide) is recommended for the adjuvant treatment of breast cancer patients. The TAC regimen is known to lead to significant hematological toxicity and induces febrile neutropenia with a rate > 20%. The use of primary G-CSF prophylaxis with the TAC regimen is recommended by guidelines. ...

Phase

0.0 miles

Learn More »

Global Non-interventional Heart Failure Disease Registry

The clinical characteristics, initial presentation, management, and outcomes of patients hospitalized with new-onset (first diagnosis) heart failure (HF) or decompensation of chronic HF are poorly understood worldwide. REPORT-HF is a global, prospective, and observational HF disease registry designed to characterize patient trajectories longitudinally during and following an index hospitalization for ...

Phase N/A

2.26 miles

Learn More »

Efficacy and Safety of DLBS3233 in Subjects With Polycystic Ovary Syndrome (PCOS)

There will be 2 groups of treatment; each group will consist of 62 subjects with the treatment regimens : Treatment I : 1 capsule of DLBS3233 100 mg (once daily) and 1 placebo caplet of Metformin XR (twice daily) Treatment II : 1 caplet of Metformin XR 750 mg (twice ...

Phase

2.26 miles

Learn More »

Tuberculosis Research of INA-RESPOND On Drug Resistance

This study is a prospective observational cohort study of TB patients who are treated or evaluated at 10 study sites. Patients presenting with cough for 2 weeks or longer with at least one additional TB symptom and a chest X-ray suggestive of TB, will be invited to be enrolled in ...

Phase N/A

2.26 miles

Learn More »